On Friday, Repare Therapeutics Inc (NASDAQ: RPTX) opened lower -2.37% from the last session, before settling in for the closing price of $1.69. Price fluctuations for RPTX have ranged from $0.89 to $4.07 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -21.89%. Company’s average yearly earnings per share was noted 21.55% at the time writing. With a float of $30.98 million, this company’s outstanding shares have now reached $42.99 million.
Repare Therapeutics Inc (RPTX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Repare Therapeutics Inc is 27.90%, while institutional ownership is 37.23%. The most recent insider transaction that took place on Mar 12 ’25, was worth 4,099. In this transaction EVP, CHIEF MEDICAL OFFICER of this company sold 3,596 shares at a rate of $1.14, taking the stock ownership to the 227,813 shares. Before that another transaction happened on Mar 12 ’25, when Company’s EVP, CHIEF SCIENTIFIC OFFICER sold 5,611 for $1.14, making the entire transaction worth $6,397. This insider now owns 80,297 shares in total.
Repare Therapeutics Inc (RPTX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.77 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.86) by 0.09.
According to the Wall Street analysts, stocks earnings will be around 21.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.08% during the next five years compared to -21.89% drop over the previous five years of trading.
Repare Therapeutics Inc (NASDAQ: RPTX) Trading Performance Indicators
Check out the current performance indicators for Repare Therapeutics Inc (RPTX). In the past quarter, the stock posted a quick ratio of 10.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.69, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.08 in one year’s time.
Technical Analysis of Repare Therapeutics Inc (RPTX)
Looking closely at Repare Therapeutics Inc (NASDAQ: RPTX), its last 5-days average volume was 0.7 million, which is a jump from its year-to-date volume of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 29.08%.
During the past 100 days, Repare Therapeutics Inc’s (RPTX) raw stochastic average was set at 46.67%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0765 in the past 14 days, which was higher than the 0.0663 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7835, while its 200-day Moving Average is $1.4561. However, in the short run, Repare Therapeutics Inc’s stock first resistance to watch stands at $1.6951. Second resistance stands at $1.7403. The third major resistance level sits at $1.7628. If the price goes on to break the first support level at $1.6274, it is likely to go to the next support level at $1.6049. Should the price break the second support level, the third support level stands at $1.5597.
Repare Therapeutics Inc (NASDAQ: RPTX) Key Stats
There are currently 42,959K shares outstanding in the company with a market cap of 70.88 million. Presently, the company’s annual sales total 53,480 K according to its annual income of -84,690 K. Last quarter, the company’s sales amounted to 250 K and its income totaled -16,740 K.
